Pricing and volume: Organic sales growth was driven by favorable pricing (value realization) and volume increases.
Margin pressure: Gross and operating margins declined due to inflation, tariffs, and unfavorable transactional foreign exchange, partially offset by supply chain productivity gains.
Segment innovation: Skin Health and Beauty growth was driven by Hair Care and Face Care, eCommerce momentum, and new product launches; Essential Health benefited from innovation in Wound Care and Baby Care.
The current average analyst rating on the shares is hold, with 1 strong buy or buy, 13 hold and no sell or strong sell. The average consensus recommendation for the personal products peer group is buy.
Wall Street's median 12-month price target for Kenvue Inc. is $20.00, about 1.7% above its August 5 closing price of $19.67. The stock recently traded at 16 times the next 12-month earnings vs. a P/E of 15 three months ago.
KVUE•
